Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
Abstract Background The administration of high-dose intravenous immunoglobulin (IVIG) is a standard treatment for the management of Kawasaki disease (KD). IVIG is known to be a highly effective and safe treatment. Case presentation We report the development of hemolytic anemia in seven children rece...
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
BMC
2024-01-01
|
| Sarja: | BMC Pediatrics |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12887-024-04546-z |